Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DEXLANSOPRAZOLE Cause Dyspnoea? 437 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 437 reports of Dyspnoea have been filed in association with DEXLANSOPRAZOLE (Dexlansoprazole). This represents 1.8% of all adverse event reports for DEXLANSOPRAZOLE.

437
Reports of Dyspnoea with DEXLANSOPRAZOLE
1.8%
of all DEXLANSOPRAZOLE reports
98
Deaths
262
Hospitalizations

How Dangerous Is Dyspnoea From DEXLANSOPRAZOLE?

Of the 437 reports, 98 (22.4%) resulted in death, 262 (60.0%) required hospitalization, and 101 (23.1%) were considered life-threatening.

Is Dyspnoea Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DEXLANSOPRAZOLE. However, 437 reports have been filed with the FAERS database.

What Other Side Effects Does DEXLANSOPRAZOLE Cause?

Chronic kidney disease (15,973) Acute kidney injury (7,599) Renal failure (6,618) End stage renal disease (4,800) Renal injury (4,320) Tubulointerstitial nephritis (2,177) Death (1,417) Rebound acid hypersecretion (1,160) Gastrooesophageal reflux disease (1,013) Drug ineffective (859)

What Other Drugs Cause Dyspnoea?

ALBUTEROL (21,856) TREPROSTINIL (16,348) AMBRISENTAN (13,367) PREDNISONE (12,830) BUDESONIDE\FORMOTEROL (11,158) TIOTROPIUM (10,863) ADALIMUMAB (10,547) DUPILUMAB (10,310) FLUTICASONE\SALMETEROL (9,783) MEPOLIZUMAB (9,192)

Which DEXLANSOPRAZOLE Alternatives Have Lower Dyspnoea Risk?

DEXLANSOPRAZOLE vs DEXMEDETOMIDINE DEXLANSOPRAZOLE vs DEXMETHYLPHENIDATE DEXLANSOPRAZOLE vs DEXMETHYLPHENIDATE\SERDEXMETHYLPHENIDATE DEXLANSOPRAZOLE vs DEXPANTHENOL DEXLANSOPRAZOLE vs DEXRAZOXANE

Related Pages

DEXLANSOPRAZOLE Full Profile All Dyspnoea Reports All Drugs Causing Dyspnoea DEXLANSOPRAZOLE Demographics